Global Menopausal Hot Flashes Therapeutics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Therapy;

Hormonal Therapy - Estrogen[Premarin and Vivelle-Dot], - Progestin and Combination Therapy, Non-Hormonal - Brisdelle.

By Distribution Channel;

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn130773207 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Menopausal Hot Flashes Therapeutics Market (USD Million), 2021 - 2031

In the year 2024, the Global Menopausal Hot Flashes Therapeutics Market was valued at USD 2,910.15 million. The size of this market is expected to increase to USD 3,783.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.8%.

The global menopausal hot flashes therapeutics market is experiencing significant growth, driven by the increasing prevalence of menopause-related symptoms and a growing awareness of treatment options. Hot flashes, one of the most common and distressing symptoms of menopause, affect millions of women worldwide, often impacting their quality of life. As the global population of postmenopausal women continues to rise due to aging demographics, the demand for effective therapeutics to manage these symptoms is expected to grow substantially. Pharmaceutical advancements and the introduction of novel therapies have further fueled market expansion.

Hormone replacement therapy (HRT) remains a widely used treatment for managing hot flashes, offering significant relief to many women. However, concerns about the potential risks associated with long-term HRT use, such as cardiovascular complications and breast cancer, have driven the development of alternative therapies. Non-hormonal options, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and herbal supplements, have gained popularity as safer alternatives for symptom management. The diversification of treatment options has broadened the scope of the market, catering to the varying needs and preferences of menopausal women.

The menopausal hot flashes therapeutics market is also shaped by increasing research and development activities aimed at introducing innovative solutions. Biopharmaceutical companies are focusing on developing targeted therapies that provide effective relief with minimal side effects. Additionally, the growing adoption of personalized medicine has paved the way for treatments tailored to individual patient profiles. Geographically, developed regions such as North America and Europe dominate the market due to advanced healthcare infrastructure and higher awareness levels, while emerging economies in Asia-Pacific and Latin America present lucrative growth opportunities driven by improving access

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Therapy
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Menopausal Hot Flashes Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers:
        1. Increasing menopausal population
        2. Growing awareness of menopause-related symptoms
        3. Advancements in treatment options
      2. Restraints:
        1. Side effects and risks of hormone replacement therapy
        2. High treatment costs
        3. Lack of awareness in emerging regions
      3. Opportunities:
        1. Development of non-hormonal treatment options
        2. Expanding healthcare infrastructure in emerging markets
        3. Rising demand for personalized medicine
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
    4. Bargaining Power of Suppliers
      1. Bargaining Power of Buyers
      2. Threat of Substitutes
      3. Threat of New Entrants
      4. Competitive Rivalry
  5. Market Segmentation
    1. Global Menopausal Hot Flashes Therapeutics Market, By Therapy, 2021 - 2031 (USD Million)
      1. Hormonal Therapy -
        1. Estrogen[Premarin and Vivelle-Dot
        2. Progestin
        3. Combination Therapy
      2. Non-Hormonal
        1. Brisdelle.
    2. Global Menopausal Hot Flashes Therapeutics Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    3. Global Menopausal Hot Flashes Therapeutics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Allergan plc
      2. Bayer AG
      3. Hisamitsu Pharmaceutical Co.
      4. Novartis International AG
      5. Novo Nordisk
      6. Pfizer
      7. Teva Pharmaceutical Industries Ltd
  7. Analyst Views
  8. Future Outlook of the Market